Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Publication Preview--Ahead of Print
    • Past Issue Archive
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
    • COVID-19 Content and Resources
  • For Authors
    • Author Policies
    • Manuscript Submission Guidelines
  • About Us
    • About AJNR
    • American Society of Neuroradiology
  • Submit a Manuscript
  • Podcasts
    • Podcasts
    • Subscribe on iTunes
  • More
    • Subscribers
    • Permissions
    • Advertisers
    • Alerts
    • Feedback

User menu

  • Subscribe
  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

  • Subscribe
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Publication Preview--Ahead of Print
    • Past Issue Archive
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
    • COVID-19 Content and Resources
  • For Authors
    • Author Policies
    • Manuscript Submission Guidelines
  • About Us
    • About AJNR
    • American Society of Neuroradiology
  • Submit a Manuscript
  • Podcasts
    • Podcasts
    • Subscribe on iTunes
  • More
    • Subscribers
    • Permissions
    • Advertisers
    • Alerts
    • Feedback
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds
Abstract

Neurotoxic potential of gadodiamide after injection into the lateral cerebral ventricle of rats.

D E Ray, J L Holton, C C Nolan, J B Cavanagh and E S Harpur
American Journal of Neuroradiology September 1998, 19 (8) 1455-1462;
D E Ray
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J L Holton
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C C Nolan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J B Cavanagh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E S Harpur
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

PURPOSE Results of a previous report showed that, if administered by intraventricular injection to access tissue normally protected by the blood-brain barrier, gadopentetate dimeglumine produced acute excitation, persistent ataxia, and widespread brain lesions in rats at 5-micromol/g brain but not at 3.8-micromol/g brain. The present study using gadodiamide was undertaken to see whether the effects were agent-specific.

METHODS Rats, surgically prepared with a lateral ventricular cannula, were administered a slow injection at 2 microL/min of gadodiamide into the lateral ventricle, and behavioral and neuropathologic changes were noted.

RESULTS Both gadodiamide and gadopentetate dimeglumine produced focal and generalized myoclonus over several hours. Gadodiamide did not produce the medium-term tremor or persistent ataxia seen after treatment with gadopentetate dimeglumine. Neuropathologic changes developed over 1 to 3 days and took three distinct forms: vacuolated thalamic lesions closely resembling those produced by gadopentetate dimeglumine; small but similar vacuolated symmetrical caudate lesions not produced by gadopentetate dimeglumine; and severe swelling and astrocytic hypertrophy and hyperplasia in the cerebellar vermis, again not produced by gadopentetate dimeglumine. Unlike gadopentetate dimeglumine, gadodiamide produced no spinal cord lesions. The cerebellar changes were seen at 1.25-micromol/g brain and above, behavioral changes at 2.5-micromol/g brain and above, and thalamic and caudate lesions at 10-micromol/g brain, the maximal dose used. Markedly reducing the rate of injecting the same volume over 28 hours prevented the acute excitation but did not reduce the severity of the morphologic effects.

CONCLUSION The acute excitatory effects of high intraventricular doses of gadopentetate dimeglumine and gadodiamide are similar and appear to be attributable to local action at the infusion site, but differences exist between the two agents in the character and topography of the distant morphologic changes. The cerebellum was the brain area most sensitive to gadodiamide in this experimental model. It is unlikely that gadodiamide would gain access to the brain at these tissue doses when used intravenously for conventional clinical imaging, but our experimental model suggested that it had some unexpectedly specific neuropathologic potential.

  • Copyright © American Society of Neuroradiology
PreviousNext
Back to top

In this issue

American Journal of Neuroradiology
Vol. 19, Issue 8
1 Sep 1998
  • Table of Contents
  • Index by author
Advertisement
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Neurotoxic potential of gadodiamide after injection into the lateral cerebral ventricle of rats.
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Neurotoxic potential of gadodiamide after injection into the lateral cerebral ventricle of rats.
D E Ray, J L Holton, C C Nolan, J B Cavanagh, E S Harpur
American Journal of Neuroradiology Sep 1998, 19 (8) 1455-1462;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Neurotoxic potential of gadodiamide after injection into the lateral cerebral ventricle of rats.
D E Ray, J L Holton, C C Nolan, J B Cavanagh, E S Harpur
American Journal of Neuroradiology Sep 1998, 19 (8) 1455-1462;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Fatal gadolinium-induced encephalopathy following accidental intrathecal administration: a case report and a comprehensive evidence-based review
  • Gadolinium-Based Contrast Agent Accumulation and Toxicity: An Update
  • Intrathecal Gadolinium-Enhanced MR Cisternography: A Comprehensive Review
  • Intrathecal Gadolinium-Enhanced MR Cisternography in the Evaluation of CSF Leakage
  • Cisternography and Ventriculography Gadopentate Dimeglumine-Enhanced MR Imaging in Pediatric Patients: Preliminary Report
  • Crossref
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Similar Articles

Advertisement

News and Updates

  • Lucien Levy Best Research Article Award
  • Thanks to our 2022 Distinguished Reviewers

Resources

  • Evidence-Based Medicine Level Guide
  • AJNR Podcast Archive
  • Librarian Resources
  • Terms and Conditions

Opportunities

  • Get Peer Review Credit from Publons

American Society of Neuroradiology

  • Neurographics
  • ASNR Annual Meeting
  • Fellowship Portal

© 2023 by the American Society of Neuroradiology | Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire